Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Biochem ; 150(1): 73-81, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21478485

ABSTRACT

Recombinant protein technology is an important tool in many industrial and pharmacological applications. Although the success rate of obtaining soluble proteins is relatively low, knowledge of protein expression/solubility under 'standard' conditions may increase the efficiency and reduce the cost of proteomics studies. In this study, we conducted a genome-scale experiment to assess the overexpression and the solubility of human full-length cDNA in an in vivo Escherichia coli expression system and a wheat germ cell-free expression system. We evaluated the influences of sequence and structural features on protein expression/solubility in each system and estimated a minimal set of features associated with them. A comparison of the feature sets related to protein expression/solubility in the in vivo Escherichia coli expression system revealed that the structural information was strongly associated with protein expression, rather than protein solubility. Moreover, a significant difference was found in the number of features associated with protein solubility in the two expression systems.


Subject(s)
Cell-Free System/metabolism , Escherichia coli/metabolism , Protein Biosynthesis , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Triticum/metabolism , DNA, Complementary/genetics , Data Interpretation, Statistical , Escherichia coli/genetics , Gene Expression , Humans , Recombinant Proteins/isolation & purification , Solubility , Triticum/genetics
2.
Hum Gene Ther ; 18(10): 925-36, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17907966

ABSTRACT

First-generation (FG) adenoviral vectors (AdVs) have been widely used not only for gene therapy but also for basic studies. Because vectors of this type lack the E1A gene that is essential for the expression of other viral genes, their expression levels in target cells have been considered low. However, we found that the viral pIX gene, located immediately downstream of the inserted expression unit of the transgene, was significantly coexpressed with the transgene in cells infected with FG AdV. Whereas CAG and SRalpha promoters activated the pIX promoter considerably through their enhancer effects, the EF1alpha promoter hardly did. Moreover, when the expression unit was inserted in the rightward orientation, not only the pIX protein but also a fusion protein consisting of the N-terminal part of transgene product and pIX were sometimes coexpressed with the transgene product through an aberrant splicing mechanism. In in vivo experiments, a LacZ-expressing AdV bearing the CAG promoter caused an elevation of alanine aminotransferase, but an AdV bearing the EF1alpha promoter produced no detectable levels. Whereas the FG AdV expressing human growth hormone under the control of the CAG promoter maintained a high hormone level for less than 1 month, the FG AdV under the control of the EF1alpha promoter maintained a high level for at least 6 months. These results suggest that pIX coexpression may be one of the main causes of AdV-induced immune responses, and that the EF1alpha promoter is probably valuable for the long-term expression of FG AdV. Thus, the in vivo utility of FG AdV should be reevaluated.


Subject(s)
Adenoviruses, Human/genetics , Capsid Proteins/genetics , Genetic Therapy , Genetic Vectors , Promoter Regions, Genetic , Alanine Transaminase/blood , Animals , Blotting, Western , Capsid Proteins/immunology , Capsid Proteins/metabolism , Cell Line, Tumor , Enhancer Elements, Genetic , Female , Gene Transfer Techniques , Human Growth Hormone/genetics , Human Growth Hormone/metabolism , Humans , Liver/immunology , Mice , Transgenes
SELECTION OF CITATIONS
SEARCH DETAIL
...